Defining the regulatory networks for muscle development

Current Opinion in Genetics and Development

Volumn 6, Issue 4, 1996, Pages 445-453

  Molkentin, Jeffery D ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; MUSCLE PROTEIN; MYOD PROTEIN; MYOGENIN; TRANSCRIPTION FACTOR;

CELL CYCLE; CELL DIFFERENTIATION; DEVELOPMENTAL GENETICS; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; MOUSE; MOUSE MUTANT; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STRUCTURAL GENE; TRANSCRIPTION REGULATION;

VERTEBRATA;

EID: 0030219748     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(96)80066-9     Document Type: Article

References (58)

1. 1. Christ B, Ordahl CP: Early stages of chick somite development. Anat Embryol (Berl) 1995, 191:381-396.
2. 2. Buffinger N, Stockdale FE: Myogenic specification in somites: induction by axial structures. Dev Biol 1995, 169:96-108.
3. 3. Stern HM, Hauschka SD: Neural tube and notochord promote in vitro myogenesis in single somite explants. Dev Biol 1995, 167:87-103.
4. 4. Stern HM, Brown AMC, Hauschka SD: Myogenesis in paraxial mesoderm: Preferential induction by dorsal neural tube and by cells expressing Wnt-1. Development 1995, 121:3675-3686. The authors address which regions of the neural tube specifically have myogenic inducing activity. They convincingly demonstrate that the dorsal neural tube region acts as an inducer of myogenesis in cultured explants of paraxial mesoderm. These results begin to establish the necessary signals involved in the specification of the myoblast lineage.
5. 5. Spense MS, Yip J, Erickson CA: The dorsal neural tube organizes the dermamyotome and induces axial myocytes in the avian embryo. Development 1996, 122:231-241.
6. 6. Munsterberg AM, Lassar AB: Combinatorial signals from the neural tube, floor plate and notochord induce myogenic bHLH gene expression in the somite. Development 1995, 121:651-660.
7. 7. Takada S, Stark KL, Shea MJ, Vassileva G, McMahon JA, McMahon AP: Wnt-3A regulates somite and tailbud formation in the mouse embryo. Genes Dev 1994, 8:174-189.
8. 8. Johnson RL, Laufer E, Riddle RD : Ectopic expression of Sonic Hedgehog alters dorsal-ventral pattering of somites. Cell 1994, 119:1165-1173.
9. 9. Fan CM, Tessier-Lavigne M: Patterning of mammalian somites by surface extoderm and notochord: evidence for sclerotome induction by a hedgehog homolog. Cell 1994, 79:1175-1186.
10. 10. Munsterberg AE, Kitajewski J, Bumcrot DA, McMahon AP, Lassar AB: Combinatorial signaling by sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. Genes Dev 1995, 9:2911-2922. The authors demonstrate that Wnt factors (which are expressed in the dorsal neural tube) and Shh (which is expressed in the notochord and ventral floorplate) can cooperate to activate myogenesis in cultured somite explants. These findings begin a definition of the specific signaling molecules involved in muscle induction by axial organs.
11. 11. Ranganayakulu G, Schulz RA, Olson EN. Wingless signaling induces nautilus expression in the ventral mesoderm of the Drosophila embryo. Dev Biol 1996, 176:143-148.
12. 12. Pourquie O, Fan C, Coltey M, Hirsinger E, Watanabe Y, Breant C, Francis-West P, Brickell P, Tessier-Lavigne M, Le Douarin NM: Lateral and axial signals involved in avian somite patterning: a role for BMP4. Cell 1996, 84:461-471. This paper shows that formation of lateral muscle cells is dependent upon antagonistic signals from the neural tube and lateral mesoderm. BMP4, which is expressed in the lateral mesoderm, is proved to be an important regulator of somite patterning. Together, these results place BMP4 in a critical pathway involved in controlling the myotomal field during development.
13. 13. Pourquie O, Coltey M, Breant C, Le Douarin NM: Control of somite patterning by signals from the neural tube. Proc Natl Acad Sci USA 1995, 92:3219-3223.
14. 14. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C: Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995, 375:768-771. This report shows that the c-met receptor is expressed in the dermamyotome and in migrating myogenic precursors cells and that targeted disruption of the c-met receptor gene prevents formation of limb muscles. These results demonstrate that c-met is required for migration of myogenic precursor cells from the dermamyotome.
15. 15. Daston G, Lamar E, Oliver M, Goulding M: Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development 1996, 122:1017-1027.
16. 16. Patapoutian A, Miner JH, Lyons GE, Wold B: Isolated sequences from the linked Myf-5 and MRF4 genes drive distinct patterns of muscle-specific expression in transgenic mice. Development 1993, 118:61-69.
17. 17. Goldhamer DJ, Brunk BP, Faerman A, King A, Shani M, Emerson CP: Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development 1995, 121:637-649.
18. 18. Asakura A, Lyons GE, Tapscott SJ: The regulation of MyoD gene expression: conserved elements mediate expression in embryonic axial muscle. Dev Biol 1995, 171:386-398.
19. 19. Tajbakhsh S, Buckingham ME: Lineage restriction of the myogenic conversion factor myf-5 in the brain. Development 1995, 121:4077-4083.
20. 20. Pinney DF, De La Brousse FC, Faerman A, Shani M, Maruyama K, Emerson CP: Quail MyoD is regulated by a complex array of cis-acting control sequences. Dev Biol 1995, 170:21-38.
21. 21. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330.
22. 22. Kiess M, Gill MR, Hamel PA: Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Differ 1995, 6:1287-1298.
23. 23. Shin EK, Shin A, Paulding C, Schaffhausen B, Yee AS: Multiple changes in E2F function and regulation occur upon muscle differentiation. Mol Cell Biol 1995, 15:2252-2262.
24. 24. Corbeil HB, Whyte P, Branton PE: Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene 1995, 11:909-920.
25. 25. Rao SS, Chu C, Kohtz DS: Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol 1994, 14:5259-5267.
26. 26. Skapek SX, Rhee J, Spicer DB, Lassar AB: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995, 267:1022-1024.
27. 27. Rao SS, Kohtz DS: Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor β. A role for cyclin D1 in control of myoblast differentiation. J Biol Chem 1995, 270:4093-4100.
28. 28. Kiess M, Gill MR, Hamel PA: Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogens 1995, 10:159-166.
29. 29. Guo K, Wang J, Andres V, Smith RC, Walsh K: MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 1995, 15:3823-3829. See annotation [31•].
30. 30. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995, 267:1018-1021. See annotation [31•].
31. Cip1 in muscle and other terminally differentiating cells. Science 1995, 267:1024-1027. These three papers [29•-31•] show that the Cdk4 inhibitor p21 is upregulated during myogenesis and is induced by MyoD. The upregulation of p21 expression provides a mechanism through which MyoD can induce cell cycle arrest during muscle differentiation.
32. 32. Andres V, Walsh K: Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 1995, 132:657-666.
33. 33. Ludolph DC, Konieczny SF: Transcription factor families: muscling in on the myogenic program. FASEB J 1995, 9:1595-1604.
34. 34. Braun T, Arnold H: myf5 and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO J 1996, 15:310-318. This paper shows that MyoD and Myf5 define distinct myogenic lineages in differentiating ES cells in culture and that the Myf5-expressing lineage is stable even in the absence of Myf5 expression.
35. 35. Cossu G, Kelly R, Tajbakhsh S, Di Donna S, Vivarelli E, Buckingham ME: Activation of different myogenic pathways: myf-5 is induced by the neural tube and MyoD by the dorsal ectoderm in mouse paraxial mesoderm. Development 1996, 122:429-437.
36. 36. Grass S, Arnold H-H, Braun T: Alterations in somite patterning of Myf-5-deficient mice: a possible role for FGF-4 and FGF-6. Development 1996, 122:141-150.
37. 37. Venuti JM, Morris JS, Vivian JL, Olson EN, Klein WH: Myogenin is required for late but not early aspects of myogenesis during mouse development. J Cell Biol 1995, 128:563-576.
38. 38. Braun T, Arnold HH: Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J 1995, 14:1176-1186.
39. 39. Patapoutian A, Yoon JK, Miner JH, Wang S, Stark K, Wold B: Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. Development 1995, 121:3347-3358.
40. 40. Zhang W, Behringer RR, Olson EN: Inactivation of the myogenic bHLH gene MRF4 results in up regulation of myogenin and rib anomalies. Genes Dev 1995, 9:1388-1399.
41. 41. Wang Y, Schnegelsbert PNJ, Dausman J, Jaenisch R: Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature 1996, 379:823-825.
42. 42. Olson EN, Perry M, Schulz RA: Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev Biol 1995, 172:2-14.
43. 43. Nurrish SJ, Treisman R: DNA binding specificity determinants in MADS-Box transcription factors. Mol Cell Biol 1995, 15:4076-4085.
44. 44. Molkentin JD, Black BL, Martin JF, Olson EN: Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of myocyte enhancer factor 2C. Mol Cell Biol 1996, 16:2627-2636.
45. 45. Lilly B, Galewsky S, Firulli AB, Schulz RA, Olson EN, Metz D: A MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis. Proc Natl Acad Sci USA 1994, 91:5662-5666.
46. 46. Nguyen HT, Bodmer R, Abmayr SM, McDermott JC, Spoerel NA: D-mef2: a Drosophila mesoderm-specific MADS box-containing gene with a biphasic expression profile during embryogenesis. Proc Natl Acad Sci USA 1994, 91:7520-7524.
47. 47. Taylor MV, Beatty KE, Hunter HK, Baylies MK: Drosophila MEF2 is regulated by twist and is expressed in both the primordia and differentiated cells of the embryonic somatic, visceral and heart musculature. Mech Dev 1995, 50:29-41.
48. 48. Lilly B, Zhao B, Ranganayakulu G, Paterson BM, Schulz RA, Olson EN: Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 1995, 267:688-693. See annotation [50••].
49. 49. Bour BA, O'Brien MA, Lockwood WL, Goldstein ES, Bodmer R, Taghert PH, Abmayr SM, Nguyen HT: Drosophila MEF2, a transcription factor that is essential for myogenesis. Gen Dev 1995, 9:730-741. See annotation [50••].
50. 50. Ranganayakulu G, Zhao B, Dokidis A, Molkentin JD, Olson EN, Schulz RA: A series of mutations in the D-MEF2 transcription factor reveals multiple functions in larval and adult myogenesis in Drosophila. Dev Biol 1995, 171:169-181. These three papers, [48••-50••], demonstrate that D-MEF2 is required for differentiation of the skeletal, cardiac, and visceral muscle lineages during Drosophila embryogenesis. D-MEF2 is the only transcription factor identified to date that controls differentiation of multiple muscle cell types.
51. 51. Schulz RA, Chromey C, Lu M-F, Zhao B, Olson EN: Expression of the D-MEF2 transcription factor in Drosophila brain suggests a role in neuronal cell differentiation. Oncogene 1996, 12:1827-1831.
52. 52. Kuisk IR, Li H, Tran D, Capetanaki Y: A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis. Dev Biol 1996, 174:1-13.
53. 53. Naidu PS, Ludolph DC, To RQ, Hinterberger TJ, Konieczny SF: Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol Cell Biol 1995, 15:2707-2718.
54. 54. Black BL, Martin JF, Olson EN: The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. J Biol Chem 1995, 270:2889-2892.
55. 55. Fickett JW: Coordinate positioning of MEF2 and myogenin binding sites. Gene 1996 172:19-32.
56. 56. Molkentin JD, Black BL, Martin JF, Olson EN: Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 1995, 83:11 25-1136. This paper shows that MEF2 is a co-factor for myogenic bHLH proteins but that MEF2 by itself does not activate myogenesis. Cooperativity between myogenic bHLH and MEF2 factors appears to be mediated by direct physical interactions between their DNA binding domains.
57. 57. Kaushal S, Schneider JW, Nadal-Ginard B, Mahdavi V: Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science 1994, 226:1236-1240.
58. 58. Groisman R, Masutani H, Leibovitch M-P, Robin P, Soudant I, Trouche D, Harel-Bellan A: Physical interaction between the mitogen-responsive serum response factor and myogenic basic-helix-loop-helix proteins. J Biol Chem 1996, 271:5258-5264. Myogenin from differentiating myoblasts was shown to bind specifically to SRF. This interaction was specific for the MADS-box of SRF and the bHLH domains of the heterodimer of E12 and myogenin. As both SRF and E-box sites are present in the promoters of a number of muscle-specific genes it suggests that this interaction has a functional consequence in regulating expression.